Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells.
D000818:Animals; D020170:Caspase 1 / Q000502:physiology; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D005260:Female; D006801:Humans; D007113:Immunity, Innate; D050839:Interferon Regulatory Factor-7 / Q000502:physiology; D053583:Interleukin-1beta / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000633:toxicity; D051379:Mice; D008810:Mice, Inbred C57BL; D011494:Protein Kinases / Q000502:physiology*; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D051193:Toll-Like Receptors / Q000502:physiology; D014158:Transcription, Genetic
D016207:Cytokines; D050839:Interferon Regulatory Factor-7; D053583:Interleukin-1beta; D008070:Lipopolysaccharides; D051193:Toll-Like Receptors; D011494:Protein Kinases; C546842:MTOR protein, human; C546843:mTOR protein, mouse; D058570:TOR Serine-Threonine Kinases; D020170:Caspase 1